Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01779856 · ClinicalTrials.gov registry record · NA
Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis.
A NA study, sponsored by Medtronic Corporate Technologies and New Ventures.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT01779856 is a NA study that has completed, run by Medtronic Corporate Technologies and New Ventures. The registered enrollment target is 81 participants.
The verdict
NCT01779856, a NA study, has completed, sponsored by Medtronic Corporate Technologies and New Ventures.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The primary objective of this study is to estimate the proportion of hemodialysis patients experiencing clinically significant cardiac arrhythmias over a 6-month period using continuous cardiac monitoring with an implanted Medtronic Reveal Insertable Cardiac Monitor (ICM) device.
Interventions
- DEVICE REVEAL Insertable Cardiac Monitor (ICM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01779856
The ClinicalTrials.gov registry entry for NCT01779856 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Corporate Technologies and New Ventures, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which REVEAL Insertable Cardiac Monitor (ICM) is the first listed.
NCT01779856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01779856 about?
NCT01779856 is a clinical study titled "Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis.". The primary objective of this study is to estimate the proportion of hemodialysis patients experiencing clinically significant cardiac arrhythmias over a 6-month period using continuous cardiac monitoring with an implanted Medtronic Reveal Insertable Cardiac Monitor (ICM) device.
What is the current status of trial NCT01779856?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2013-01. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01779856?
The interventions under investigation include: REVEAL Insertable Cardiac Monitor (ICM) (DEVICE).
Who is sponsoring clinical trial NCT01779856?
This trial is sponsored by Medtronic Corporate Technologies and New Ventures, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.